Operational Costs Compared: SG&A Analysis of PTC Therapeutics, Inc. and Evotec SE

SG&A Expenses: PTC vs. Evotec's Decade-Long Journey

__timestamp	Evotec SE	PTC Therapeutics, Inc.
Wednesday, January 1, 2014	17990000	44820000
Thursday, January 1, 2015	25166000	82080000
Friday, January 1, 2016	27013000	97130000
Sunday, January 1, 2017	42383000	121271000
Monday, January 1, 2018	57012000	153548000
Tuesday, January 1, 2019	66546000	202541000
Wednesday, January 1, 2020	77238000	245164000
Friday, January 1, 2021	105445000	285773000
Saturday, January 1, 2022	156190000	325998000
Sunday, January 1, 2023	169610000	332540000

Igniting the spark of knowledge

A Decade of SG&A: PTC Therapeutics vs. Evotec SE

In the ever-evolving landscape of biotechnology, operational efficiency is paramount. Over the past decade, PTC Therapeutics, Inc. and Evotec SE have demonstrated contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, PTC Therapeutics saw a staggering 642% increase in SG&A costs, peaking at over three times their initial expenditure. In contrast, Evotec SE's expenses grew by 843%, reflecting a more aggressive expansion strategy.

Key Insights

2014-2017: Both companies maintained moderate growth, with PTC's expenses consistently outpacing Evotec's by approximately 2.5 times.
2018-2023: A significant surge in costs for both, with PTC maintaining a lead, suggesting a focus on scaling operations.

This analysis underscores the strategic choices each company has made in managing operational costs, offering a window into their growth philosophies.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025

Similar Statistics

Vertex Pharmaceuticals Incorporated vs Evotec SE: SG&A Expense Trends

SG&A Efficiency Analysis: Comparing Zoetis Inc. and PTC Therapeutics, Inc.

Selling, General, and Administrative Costs: argenx SE vs Evotec SE

Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or PTC Therapeutics, Inc.

Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE

Breaking Down SG&A Expenses: Viatris Inc. vs PTC Therapeutics, Inc.

Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Evotec SE

Selling, General, and Administrative Costs: BioMarin Pharmaceutical Inc. vs Evotec SE

Comparing SG&A Expenses: Alkermes plc vs Evotec SE Trends and Insights

Cost Management Insights: SG&A Expenses for Apellis Pharmaceuticals, Inc. and Evotec SE

Comparing SG&A Expenses: PTC Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights

Cost Management Insights: SG&A Expenses for Arrowhead Pharmaceuticals, Inc. and Evotec SE